Despite a relatively slow start to respiratory disease season, low vaccination rates threaten that trend and the rapid rise of some illnesses is already putting children at increased risk. Overall, ...

Patients with SARD-ILD-PPF who continued nintedanib for 12 months or longer had better outcomes than those who discontinued therapy.

Public Health Relevance Statement: Idiopathic Pulmonary Fibrosis (IPF) is fatal lung disorder for which no U.S. FDA-approved drugs currently exist. This project will lead to the development of novel ...

Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...

There are many types of respiratory diseases, such as COPD, asthma, and obstructive sleep apnea. Smoking and exposure to certain substances are common risk factors. Respiratory diseases are conditions ...

The thorax, the part of the body between the neck and abdomen, provides medical professionals with a valuable window into a patient's respiratory health. By evaluating sound vibrations produced by the ...

Renovaro Inc. announces funding approval for LUMINA, a platform detecting minimal residual disease in lung cancer using multi-omics and AI. Renovaro Inc. announced that its subsidiary, RenovaroCube, ...

Please provide your email address to receive an email when new articles are posted on . Diseases of the heart topped the 2022 list, and chronic lower respiratory diseases occupied the sixth spot. In ...